This purchase includes development rights for 35MW of wind power capacity, reflecting the company’s commitment to renewable energy and lowering costs.
“This acquisition serves as a blueprint for how the energy and data center sectors can collaborate to create long-term value while advancing sustainability initiatives,” said Fred Thiel, MARA’s Chairman and CEO.
<script type="application/ld+json">
{
"@context": "https://schema.org",
"@type": "Article",
"mainEntityOfPage": {
"@type": "WebPage",
"@id": "https://www.themoney.game/stories/mara-acquires-wind-farm-to-drive-sustainable-digital-asset-operations"
},
"headline": "MARA Acquires Wind Farm to Drive Sustainable Digital Asset Operations",
"description": "This purchase includes development rights for 35MW of wind power capacity, reflecting the company’s commitment to renewable energy and lowering costs.",
"image": "",
"author": {
"@type": "Organization",
"name": "The Money Game",
"url": "https://www.themoney.game"
},
"publisher": {
"@type": "Organization",
"name": "",
"logo": {
"@type": "ImageObject",
"url": ""
}
},
"datePublished": "2024-12-04"
}
</script>
Actions
Pages
Subscribe for newsletter
Stories
Gulfstream completed their world-first trans-Atlantic flight powered by 100% Sustainable Aviation Fuel (SAF). SAF consists entirely of Hydroprocessed Esters and Fatty Acids (pure HEFA), derived from refinement of renewable inputs like oils and fats. SAF boasts a minimum of 70% lower lifecycle CO2 emissions compared to fossil-based jet fuel.
Achieving environmental sustainability for the aviation industry is now tangible. SAF could become commercially viable and propel more climate friendly advancements in the future.
“Gulfstream is innovating for a sustainable future,” said Mark Burns, President of Gulfstream. “One of the keys to reaching business aviation’s long-term decarbonization goals is the broad use of SAF in place of fossil-based jet fuel. The completion of this world-class flight helps to advance business aviation’s overarching sustainability mission and create positive environmental impacts for future generations.”
The success of Gulfstream's flight is expected to boost more exploration into SAF's capabilities and compatibility, influencing both regulatory frameworks and market dynamics towards more sustainable aviation practices.
SAF has limited current market supply and prices are considerably higher than conventional fossil-based fuels. Presently, SAF constitutes less than 0.1% of jet fuel volumes, and existing fuel standards permit only a 50% SAF blend in commercial jet engines.
Story
Genentech, a Roche biotech subsidiary, is partnering with Nvidia in a multi-year deal to leverage artificial intelligence for faster, more efficient drug development. By leveraging AI research, Genentech hopes to speed up drug discovery and simultaneously improve Nvidia’s own drug discovery software, BioNemo.
Biotech companies are relying on AI increasingly to expedite the timeline from drug discovery to disease target and human clinical trials. The ability to deliver a new, critical drug to the market is crucial for saving lives and giving pharmaceutical companies a competitive edge.
“Our collaboration with NVIDIA builds on our long history of successfully inventing and deploying technology in ways that were not initially apparent to others,” said Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED).
This partnership involves the exchange of expertise between the two companies, both top in their fields of AI and biotech research. Nvidia’s venture arm has invested in other biotech startups so these types of collaborations aren’t slowing down any time soon.
Nvidia is known for their advanced computing chips but now has extended their capabilities to imaging and claim they can predict protein structures and screen small molecules accurately and quickly. This raises questions about the implications of AI in medicine and how it can affect the regulatory landscape.
Genentech's venture into AI includes a $12 billion collaboration with Recursion in 2021. This partnership targets over 40 programs in neuroscience and oncology, further highlighting Genentech's steady trajectory towards AI-driven innovation in pharmaceuticals.
Story
Lockheed Martin, leading US defense security company, is set to launch a satellite into low Earth orbit in 2024, as part of their space-based 5G network initiative. This project aims to enhance global connectivity and advance military communication capabilities.
This advancement integrates space technology with terrestrial networks to meet the rising demand for reliable, high-speed communication in remote areas. This move highlights the importance of space assets in global communications.
“Space will be the major enabler of being able to use 5G across different platforms. “It’s been slower to get traction because of the cost, and you’ve got to have standards to be able to make this work across the industry," said Joe Rickers, VP of connectivity, transport and access at Lockheed Martin. "It’s really starting to come together. We’ve still got a ways to go but we’ve seen a lot of progress.”
This launch could lead to increased adoption of space-based 5G networks, opening new opportunities in both civilian and defense sectors.
Is this US defense darling trying to give Space X’s Starlink a run for their money by moving in to the satellite internet space? This project also straddles the line between defense and commercial interests, raising questions about the balance of security and accessibility in global communications.
Story
Innovators
Scroll
Open
Close